Pharma News

MedPlus has recently launched e-commerce service ‘Click. Pick & Save’ in Delhi and NCR area. With this launch, the service is available in all the top metro areas of the country except Mumbai.

Researchers have now identified that absence of a brain chemical can lead to hyperactivity and sleeplessness. The findings were found in the Neuron. These findings could help researchers to develop new drugs that promote better sleep, or control hyperactivity in people with the medical condition mania.

A new drug, called PF-04449913, which was found promising for treating blood cancer is now in phase II clinical trials. The study appeared online in the The Lancet Hematology.

A Training Workshop was conducted on 5th Aug, 2015 by Ms. Monisha Mullick of Goldfield Fragrances, Mumbai in collaboration with Mikasa Cosmetics & Nirma University, Ahmedabad.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of Merck's investigational antibiotic Zerbaxa (ceftolozane and tazobactam). This is used for the treatment of the complicated intra-abdominal infections, acute pyelonephritis, and complicated urinary tract infections in adults.

A new study says using omega-3 fatty acids in anti-tumor medications may improve treatment response and quality of life for cancer patients.  This study published in Journal of Parenteral and Enteral Nutrition.

A new therapy discovered that cuts off the way some cancer cells communicate significantly and slows the rapid spread of a common and deadly brain tumor. The study was published in Cell Reports.

Breast cancer survivors are especially vulnerable to dyspareunia, or painful sexual intercourse, because their treatment mainly focuses on eradicating the sex hormone estrogen. A new research has suggested that application of liquid lidocaine, a common local anesthetic, may significantly improve sexual function of breast cancer survivors who experience pain during sexual intercourse. The research appeared online in the Journal of Clinical Oncology.

Medical researchers have claimed that men who experience erectile dysfunction might face twice the risk of Type 2 Diabetes compared to men without such sexual incapability. The story is published in Annals of Family Medicine.